44 related articles for article (PubMed ID: 3606084)
1. Comparative Genomic Analysis of
Yuan C; Yin Z; Wang J; Qian C; Wei Y; Zhang S; Jiang L; Liu B
Front Microbiol; 2019; 10():2774. PubMed ID: 31866966
[No Abstract] [Full Text] [Related]
2. Community-Acquired Pneumonia and Empyema Caused by Citrobacter koseri in an Immunocompetent Patient.
Ariza-Prota MA; Pando-Sandoval A; García-Clemente M; Fernández R; Casan P
Case Rep Pulmonol; 2015; 2015():670373. PubMed ID: 26634165
[TBL] [Abstract][Full Text] [Related]
3. Complete Genome Sequence of Citrobacter freundii Myophage Moon.
Edwards GB; Luna AJ; Hernandez AC; Kuty Everett GF
Genome Announc; 2015 Jan; 3(1):. PubMed ID: 25635027
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistant citrobacter: an unusual cause of liver abscess.
Kumar P; Ghosh S; Rath D; Gadpayle AK
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23608848
[TBL] [Abstract][Full Text] [Related]
5. Citrobacter brain abscesses in neonates: early surgical intervention and review of the literature.
Chowdhry SA; Cohen AR
Childs Nerv Syst; 2012 Oct; 28(10):1715-22. PubMed ID: 22526440
[TBL] [Abstract][Full Text] [Related]
6. Citrobacter infections in a general hospital: characteristics and outcomes.
Samonis G; Karageorgopoulos DE; Kofteridis DP; Matthaiou DK; Sidiropoulou V; Maraki S; Falagas ME
Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):61-8. PubMed ID: 18682995
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Campoli-Richards DM; Monk JP; Price A; Benfield P; Todd PA; Ward A
Drugs; 1988 Apr; 35(4):373-447. PubMed ID: 3292209
[TBL] [Abstract][Full Text] [Related]
8. Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Campoli-Richards DM; Chaplin S; Sayce RH; Goa KL
Drugs; 1989 Nov; 38(5):703-56. PubMed ID: 2689137
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone antimicrobial agents.
Wolfson JS; Hooper DC
Clin Microbiol Rev; 1989 Oct; 2(4):378-424. PubMed ID: 2680058
[TBL] [Abstract][Full Text] [Related]
10. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.
Samonis G; Anaissie E; Elting L; Bodey GP
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):479-85. PubMed ID: 1915382
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods.
Wang JT; Chang SC; Chen YC; Luh KT
J Microbiol Immunol Infect; 2000 Dec; 33(4):258-62. PubMed ID: 11269372
[TBL] [Abstract][Full Text] [Related]
12. [Spondylitis due to Citrobacter diversus. Case report and review of Citrobacter diversus infections].
Müllner GF; Keller H
Schweiz Med Wochenschr; 1992 Aug; 122(31-32):1173-7. PubMed ID: 1496345
[TBL] [Abstract][Full Text] [Related]
13. Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature.
Lipsky BA; Hook EW; Smith AA; Plorde JJ
Rev Infect Dis; 1980; 2(5):746-60. PubMed ID: 6763304
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Citrobacter species to various antimicrobial agents.
Samonis G; Ho DH; Gooch GF; Rolston KV; Bodey GP
Antimicrob Agents Chemother; 1987 May; 31(5):829-30. PubMed ID: 3606084
[TBL] [Abstract][Full Text] [Related]
15. Citrobacter bacteremia in a tertiary care hospital.
Gupta N; Yadav A; Choudhary U; Arora DR
Scand J Infect Dis; 2003; 35(10):765-8. PubMed ID: 14606621
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility patterns (antibiograms) as an aid in differentiating Citrobacter species.
Southern PM; Bagby MK
Am J Clin Pathol; 1977 Feb; 67(2):187-9. PubMed ID: 836626
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
